Bioxytran

Bioxytran

Pharmaceuticals, 75 2nd Ave Ste 605, NEEDHAM, Massachusetts, 02494, United States, 11-50 Employees

bioxytraninc.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: 61********

Who is BIOXYTRAN

Developing new drugs under FDA regulation for hypoxia brain and heart ischemia and viral infection like coronavirus and influenza.

Read More

map
  • 75 2nd Ave Ste 605, NEEDHAM , Massachusetts, 02494, United States Headquarters: 75 2nd Ave Ste 605, NEEDHAM , Massachusetts, 02494, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • David Platt CEO:   David Platt

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 54 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BIOXYTRAN

Bioxytran Org Chart and Mapping

David Platt

Chief Executive Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Bioxytran

Answer: Bioxytran's headquarters are located at 75 2nd Ave Ste 605, NEEDHAM, Massachusetts, 02494, United States

Answer: Bioxytran's phone number is 61********

Answer: Bioxytran's official website is https://bioxytraninc.com

Answer: Bioxytran's revenue is $1 Million to $5 Million

Answer: Bioxytran's SIC: 2834

Answer: Bioxytran's NAICS: 54

Answer: Bioxytran has 11-50 employees

Answer: Bioxytran is in Pharmaceuticals

Answer: Bioxytran contact info: Phone number: 61******** Website: https://bioxytraninc.com

Answer: Developing new drugs under FDA regulation for hypoxia brain and heart ischemia and viral infection like coronavirus and influenza.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access